Genetic and environmental factors in the etiology of schizophrenia - towards mainstreaming

Agnieszka Łaba-Stefanek 1 , Ewelina Dziwota 2  und Marcin Olajossy 2
  • 1 Medical Students’ Association, Medical University of Lublin
  • 2 II Department of Psychiatry and Psychiatric Rehabilitation, Medical University of Lublin


The prevalence of schizophrenia in a population is about 1%. Many efforts are constantly made to find the cause of this mental illness. Authors of this article provide groups of factors influencing the development of the disease. Among these factors, genetics seems to be an interesting and reasonable trend of exploration. GWAS research studies allow not only determining the point mutations in the genome, but also try to give an answer to the question about the biological mechanisms of disease. A microRNA MIR137, which is involved in neurogenesis and maturation of neurons may be an example. However, the genetic component may not always be sufficient to trigger symptoms. Definitely, a large group of environmental factors has an important role. Schizophrenia is a complex disease in which many genes interact with the environment. This article is a presentation of genes and the impact of various external environmental factors, leading to the onset of schizophrenia. Interrelationship between polygenic determinant of disease and the impact of both environmental and social factors in future will certainly become the field of interest for research concerning the etiology and course of schizophrenia-spectrum disorders.

Falls das inline PDF nicht korrekt dargestellt ist, können Sie das PDF hier herunterladen.

  • 1. Oniszczenko W., Dragan W.Ł. Genetyka zachowania w psychologii i psychiatrii. Wydawnictwo Naukowe SCHOLAR: 2008.

  • 2. Ritsner M.S. Handbook of Schizophrenia Spectrum Disorders. Volume 1. 2011.

  • 3. Jarema M. Psychiatria. Podręcznik dla studentów medycyny. PZWL: 2011

  • 4. Girard S.L., Dion P.A., Rouleau G.A. Schizophrenia Genetics: Putting All the Pieces Together; 2012.

  • 5. Suchanecka A., Grzywacz A., Samochowiec J. Gen ANKK1 w psychiatrii, 2011

  • 6. Sanders A.R. Genetics of Schizophrenia, 2014.

  • 7. Hauser J.W. Co badania asocjacyjne całego genomu (GWAS) wniosły do psychiatrii?, 2013.

  • 8. Bergen S.E., Petryshen T.L. Genome-wide association studiem (GWAS) of schizophrenia: does bigger lead to better results?, 2013.

  • 9. Hosak L., Silhan P., Hosakowa J. Genomic copy number variations: A breakthrough in our knowledge on schizophrenia etiology?, 2012.

  • 10. Kotlar A.V., Mercer K.B., Zwick M.E., Mulle J.G. New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings, 2015

  • 11. Gumerov V., Hegyi H. MicroRNA-derived network analysis of differentially methylated genes in schizophrenia, implicating GABA receptor B1 [GABBR1] and protein kinase B [AKT1], 2015.

  • 12. Ripke S., Sanders A.R., Kendler K.S. Genome-wide association study identifies five new schizophrenia loci, 2011.

  • 13. Kirov G., Pocklington A.J., Holmans P., Ivanov D., Ikeda M. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia, 2012.

  • 14. Gulsuner S., Walsh T., Watts A.C., Lee M.K., Thornton A.M. Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network, 2013.

  • 15. 15.Schmitt A., Malchow B., Hasan A., Fallkai P. The impact of environmental factors in severe psychiatric disorders, 2014.

  • 16. Hauser J. Interakcja czynników genetycznych i środowiskowych w schizofrenii, 2007.

  • 17. AbdelMalik P., Husted J., Chow E.W.C., Bassett A.S. Childhood Head Injury and Expression of Schizophrenia in Multiply Affected Families, 2003.

  • 18. Renard J., Rosen L.G., Loureiro M., De Oliveira C., Schmid S., Rushlow W.J. et al: Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex, 2016.

  • 19. Manseau M.W., Goff D.C. Cannabinoids and Schizophrenia: Risks and Therapeutic Potential, 2015.

  • 20. Dervaux A., Krebs M.O., Laqueille X. Cannabis-induced cognitive and psychiatric disorders, 2015.


Zeitschrift + Hefte